Identifying Current Lab Trends from Labcorp & Quest Experience

By Robert Michel | From the Volume XXXI, No. 11 – August 12, 2024 Issue

CEO SUMMARY: Many different factors influence the operations of clinical laboratories in the United States today. One good source of competitive business intelligence is for lab administrators to follow the quarterly earnings calls of the nation’s two biggest public lab corporations. Wi…

Read More

---

April 29, 2024, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXI, No. 6 – April 29, 2024 Issue

It may be that the genetic data cat is out of the bag already. Nonetheless, lawmakers in Delaware are considering a bill that—among other things—would prevent life insurance companies from buying or using genetic testing data if it was obtained from ancestry companies and not from medical records…

Read More

---

2022’s Top 10 Lab Stories Confirm Challenging Times

By Scott Wallask | From the Volume XXIX, No. 17 – December 12, 2022 Issue

CEO SUMMARY: There are valuable insights to be gleaned from The Dark Report’s “Top 10 Lab Industry Stories for 2022.” Several of this year’s story picks involve external forces reshaping healthcare in the United States in profound ways. Other story picks for 2022 illustrate …

Read More

---

July 18, 2022 Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXIX, No. 10 – July 18, 2022 Issue

Given that monkeypox cases continue to rise, the federal government likewise is ramping up its response. In June, the federal Centers for Disease Control and Prevention (CDC) began shipping monkeypox tests to five commercial laboratories: Aegis Science, Labcorp, Mayo Clinic La…

Read More

---

Pathology Firm’s Investment in AI Signals a New Trend

By Robert Michel | From the Volume XXIX, No. 3 – February 22, 2022 Issue

This is an excerpt of a 1,436-word article in the February 22, 2022 issue of  THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: Australian artificial intelligence (AI) company Harrison.ai got AU$129 million from multiple inve…

Read More

---

Artificial Intelligence ‘Invades’ Pathology, Billing

By R. Lewis Dark | From the Volume XXIX, No. 3 – February 22, 2022 Issue

Predictions about the potential of artificial intelligence (AI) to transform nearly every area of healthcare are about to become reality. For the profession of laboratory medicine, AI is making speedy inroads into two areas. The first is anato…

Read More

---

Pathology Investment in AI Signals New Trend

By Robert Michel | From the Volume XXIX, No. 3 – February 22, 2022 Issue

CEO SUMMARY: Australian artificial intelligence (AI) company Harrison.ai got AU$129 million from multiple investors, including both Sonic Healthcare—Australia’s largest pathology group—and I-MED Radiology Network. Pathology’s growing interest in AI tools, along with the grow…

Read More

---

Sonic Healthcare Acquires ProPath, PathGroup Buys Path Consultants

By Robert Michel | From the Volume XXIX, No. 2 – January 31, 2022 Issue

CONSOLIDATION AMONG PRIVATE PRACTICE ANATOMIC PATHOLOGY GROUPS continues with news that two large regional pathology groups decided to sell to larger pathology companies.  The first transaction announced was on Dec. 16, 2021, when Sonic Healthcare …

Read More

---

December 20, 2021 Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXVIII, No. 17 – December 20, 2021 Issue

In Europe, Switzerland-based Unilabs will be acquired by a Danish company. Unilabs owns laboratories in at least 11 European countries and posted revenue of €2 billion euros (US $2.26 billion) in the financial year ending September. The seller is Apax Partners, a private equity compan…

Read More

---

New Class of IVD Firms Wants to Serve POCT in Near-Patient Settings

By Robert Michel | From the Volume XXVIII, No. 13 – September 27, 2021 Issue

CEO SUMMARY: Our second installment in this series describes an emerging new clas…

Read More

---